MedTrace Logo

Effect of Electromyostimulation on Bone

NCT01296776 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2015-12-02

No results posted yet for this study

Summary

Although there is some evidence that whole body electromyostimulation(WB-EMS) affect bone via its acute and longitudinal effects on muscle mass and strength, the corresponding impact on bone density and falls in older adults has not been assessed yet. The investigators hypothesize that WB-EMS significantly affects bone parameters as assessed by DXA, and significantly reduce fall rate and ratio in a cohort of frail elderly women.

Conditions

Interventions

OTHER

wellness control group.

Light physical exercise and relaxation program once a week in blocks of 10 weeks with breaks of 10 weeks between the blocks. The low-intensity, low-volume program was designed to avoid impact on our endpoints.

DEVICE

whole-body electromyostimulation

3 sessions of 18 min/14 (1,5 x week)days over 12 months. 10 low-intensity/low amplitude exercises with electromyostimulation equipment with 85 Hz with periods of 6 sec of current and 4 sec of rest.

Sponsors & Collaborators

  • City of Erlangen

    collaborator UNKNOWN

  • Behinderten- und Versehrten-Sportverband Bayern e.V.

    collaborator OTHER

  • Institute of Physical Education and Sports Sciences

    collaborator OTHER

  • University of Erlangen-Nürnberg Medical School

    lead OTHER

Principal Investigators

  • Willi A Kalender, PhD, MD · University of Erlangen-Nürnberg Medical School

  • Wolfgang Kemmler, PhD · University of Erlangen-Nürnberg Medical School

  • Simon von Stengel, PhD · University of Erlangen-Nürnberg Medical School

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
70 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01296776 on ClinicalTrials.gov